Center for Atherothrombotic Research in Tromsø, Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway.
J Hepatol. 2011 Dec;55(6):1346-52. doi: 10.1016/j.jhep.2011.03.013. Epub 2011 Apr 13.
BACKGROUND & AIMS: The low density lipoprotein receptor-related protein-1 (LRP-1) is a large, multifunctional endocytic receptor from the LDL receptor family, highly expressed in liver parenchymal cells (PCs), neurons, activated astrocytes, and fibroblasts. The aim of the study was to investigate if liver sinusoidal endothelial cells (LSECs), highly specialized scavenger cells, express LRP-1.
To address this question, experiments were performed in vivo and in vitro to determine if receptor associated protein (RAP) and trypsin-activated α(2)-macroglobulin (α(2)M∗) were endocytosed in LSECs.
Both ligands were cleared from the circulation mainly by the liver. Hepatocellular distribution of intravenously administered ligands, assessed after magnetic bead cell separation using LSEC- and KC-specific antibodies, showed that PCs contained 93% and 82% of liver-associated (125)I-RAP and (125)I-α(2)M∗, whereas 5% and 11% were associated with LSECs. Uptake of RAP and α(2)M∗ in the different liver cell population in vitro was specific and followed by degradation. The uptake of (125)I-RAP was not inhibited by ligands to known endocytosis receptors in LSECs, while uptake of (125)I-α(2)M∗ was significantly inhibited by RAP, suggesting the involvement of LRP-1. Immunofluorescence using LRP-1 antibody showed positive staining in LSECs. Ligand blot analyses using total cell proteins and (125)I-RAP followed by mass spectrometry further confirmed and identified LRP-1 in LSECs.
LSECs express functional LRP-1. An important implication of our findings is that LSECs contribute to the rapid removal of blood borne ligands for LRP-1 and may thus play a role in lipid homeostasis.
载脂蛋白 B 受体相关蛋白 1(LRP-1)是 LDL 受体家族中的一种大型多功能内吞受体,在肝实质细胞(PCs)、神经元、活化的星形胶质细胞和成纤维细胞中高表达。本研究旨在探讨肝脏窦内皮细胞(LSEC)是否表达 LRP-1,LSEC 是高度特化的清道夫细胞。
为了研究这个问题,我们在体内和体外进行了实验,以确定受体相关蛋白(RAP)和胰蛋白酶激活的α2-巨球蛋白(α2M∗)是否被 LSEC 内吞。
两种配体主要在肝脏中从循环中清除。用 LSEC 和 KC 特异性抗体通过磁珠细胞分离后评估静脉内给予配体的肝内分布,结果显示 93%和 82%的肝脏相关(125)I-RAP 和(125)I-α2M∗存在于 PCs 中,而 5%和 11%与 LSEC 相关。在体外,不同肝细胞群体对 RAP 和α2M∗的摄取是特异性的,并随后被降解。(125)I-RAP 的摄取不受 LSEC 中已知内吞受体的配体抑制,而(125)I-α2M∗的摄取被 RAP 显著抑制,提示 LRP-1 的参与。用 LRP-1 抗体进行免疫荧光显示 LSEC 呈阳性染色。用总细胞蛋白和(125)I-RAP 进行配体印迹分析,随后进行质谱分析,进一步证实并鉴定了 LSECs 中的 LRP-1。
LSEC 表达功能性 LRP-1。我们研究结果的一个重要意义是,LSEC 有助于快速清除血液中 LRP-1 的配体,因此可能在脂质稳态中发挥作用。